P
This company develops drug candidates formulated for intranasal delivery to improve bioavailability and ease of use for patients. Their technology bypasses the blood-brain barrier to enhance drug delivery for central nervous system (CNS) therapeutics. Precedent's focus includes addressing respiratory dysfunction in conditions like ALS through improved drug targeting.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops drug candidates formulated for intranasal delivery to improve bioavailability and ease of use for patients. Their technology specifically targets the olfactory epithelium to bypass the blood-brain barrier for CNS therapeutic delivery. Precedent's pipeline includes candidates addressing respiratory dysfunction, a primary cause of mortality in conditions like ALS.